instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'LIDOCAINE'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | Epidural | DrugAdministrationRoute | CC BY-NC | 33616459 | 19,014,130 | 2021-02 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | Epidural | DrugAdministrationRoute | CC BY-NC | 33616459 | 19,014,130 | 2021-02 |
What was the dosage of drug 'HYALURONIDASE (HUMAN RECOMBINANT)'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | 1 MILLILITER | DrugDosageText | CC BY-NC | 33616459 | 19,360,157 | 2021-02 |
What was the dosage of drug 'LIDOCAINE'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | 0.3 MILLILITER | DrugDosageText | CC BY-NC | 33616459 | 19,360,157 | 2021-02 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | 1 MILLILITER | DrugDosageText | CC BY-NC | 33616459 | 19,360,157 | 2021-02 |
What was the dosage of drug 'SUS SCROFA PLACENTA'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | 2 MILLILITER | DrugDosageText | CC BY-NC | 33616459 | 19,360,157 | 2021-02 |
What was the outcome of reaction 'Meningitis chemical'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | Recovered | ReactionOutcome | CC BY-NC | 33616459 | 19,360,157 | 2021-02 |
What was the outcome of reaction 'Pneumocephalus'? | Chemical meningitis after cervical transforaminal epidural steroid injection: a case report.
We herein report a case of chemical meningitis that developed after cervical transforaminal steroid injection. A 49-year-old man presented with symptoms of meningitis (severe headache and neck stiffness) after cervical transfor... | Recovered | ReactionOutcome | CC BY-NC | 33616459 | 19,014,130 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Acute Villitis and Intravascular Microorganisms in Fetal Vessels: A Case Report and Literature Review of an Unusual Histopathological Finding.
Optimal management of intrauterine infection to avoid serious adverse perinatal outcomes entails prompt administration of antibiotics and consideration of early delivery of the ... | CLINDAMYCIN, MEROPENEM | DrugsGivenReaction | CC BY | 33617361 | 19,394,455 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Acute Villitis and Intravascular Microorganisms in Fetal Vessels: A Case Report and Literature Review of an Unusual Histopathological Finding.
Optimal management of intrauterine infection to avoid serious adverse perinatal outcomes entails prompt administration of antibiotics and consideration of early delivery of the ... | CLINDAMYCIN, MEROPENEM | DrugsGivenReaction | CC BY | 33617361 | 19,414,928 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
Immune checkpoint inhibitors (ICIs) have led to major therapeutic advances in the management of malignancy. Despite promising outcomes for some cancers, ICIs are linked to unique side-effects known as immune-rela... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33617506 | 19,188,841 | 2021-02-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated enterocolitis'. | Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
Immune checkpoint inhibitors (ICIs) have led to major therapeutic advances in the management of malignancy. Despite promising outcomes for some cancers, ICIs are linked to unique side-effects known as immune-rela... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33617506 | 19,188,841 | 2021-02-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated hepatitis'. | Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
Immune checkpoint inhibitors (ICIs) have led to major therapeutic advances in the management of malignancy. Despite promising outcomes for some cancers, ICIs are linked to unique side-effects known as immune-rela... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33617506 | 19,188,841 | 2021-02-14 |
What was the outcome of reaction 'Death'? | Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
Immune checkpoint inhibitors (ICIs) have led to major therapeutic advances in the management of malignancy. Despite promising outcomes for some cancers, ICIs are linked to unique side-effects known as immune-rela... | Fatal | ReactionOutcome | CC BY | 33617506 | 19,188,841 | 2021-02-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Not COVID-19, Don't Overlook Pneumocystis in Patients on Gefitinib!
An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was tw... | BETAMETHASONE, GEFITINIB, HYDROCORTISONE, OSIMERTINIB | DrugsGivenReaction | CC BY | 33617512 | 19,083,915 | 2021-02-21 |
What was the outcome of reaction 'Pneumocystis jirovecii pneumonia'? | Not COVID-19, Don't Overlook Pneumocystis in Patients on Gefitinib!
An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was tw... | Recovered | ReactionOutcome | CC BY | 33617512 | 19,064,604 | 2021-02-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug abuse'. | Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments.
BACKGROUND
The mu-opioid agonist methadone is administered orally and used in opioid detoxification and in the treatment of moderate-to-severe pain. Acute oral methadone-use and -abuse have been ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33618681 | 18,992,539 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalopathy'. | Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments.
BACKGROUND
The mu-opioid agonist methadone is administered orally and used in opioid detoxification and in the treatment of moderate-to-severe pain. Acute oral methadone-use and -abuse have been ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33618681 | 18,992,539 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxic-ischaemic encephalopathy'. | Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments.
BACKGROUND
The mu-opioid agonist methadone is administered orally and used in opioid detoxification and in the treatment of moderate-to-severe pain. Acute oral methadone-use and -abuse have been ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33618681 | 18,992,539 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments.
BACKGROUND
The mu-opioid agonist methadone is administered orally and used in opioid detoxification and in the treatment of moderate-to-severe pain. Acute oral methadone-use and -abuse have been ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33618681 | 18,992,539 | 2021-02-22 |
What was the administration route of drug 'METHADONE HYDROCHLORIDE'? | Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments.
BACKGROUND
The mu-opioid agonist methadone is administered orally and used in opioid detoxification and in the treatment of moderate-to-severe pain. Acute oral methadone-use and -abuse have been ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33618681 | 18,992,539 | 2021-02-22 |
What was the dosage of drug 'METHADONE HYDROCHLORIDE'? | Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments.
BACKGROUND
The mu-opioid agonist methadone is administered orally and used in opioid detoxification and in the treatment of moderate-to-severe pain. Acute oral methadone-use and -abuse have been ... | 3 ? 2.5 ML (LIQUID METHADONE) | DrugDosageText | CC BY | 33618681 | 18,992,539 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion induced'. | Valproate use in women aged 15-44 years: an observational study in general practice.
BACKGROUND
Valproate is a known teratogen. In April 2018, the Medicines and Healthcare products Regulatory Agency (MHRA) restricted its use in women and banned use in pregnancy, except for epilepsy with no other effective treatment. To... | DIVALPROEX SODIUM | DrugsGivenReaction | CC BY | 33619016 | 19,419,409 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Valproate use in women aged 15-44 years: an observational study in general practice.
BACKGROUND
Valproate is a known teratogen. In April 2018, the Medicines and Healthcare products Regulatory Agency (MHRA) restricted its use in women and banned use in pregnancy, except for epilepsy with no other effective treatment. To... | DIVALPROEX SODIUM | DrugsGivenReaction | CC BY | 33619016 | 19,419,409 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sarcoidosis'. | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | SECUKINUMAB | DrugsGivenReaction | CC BY-NC | 33619146 | 19,002,719 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | ADALIMUMAB, FOLIC ACID, METHOTREXATE, SECUKINUMAB, SULFASALAZINE | DrugsGivenReaction | CC BY-NC | 33619146 | 19,020,282 | 2021-02-22 |
What was the administration route of drug 'ADALIMUMAB'? | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33619146 | 19,020,282 | 2021-02-22 |
What was the administration route of drug 'FOLIC ACID'? | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | Oral | DrugAdministrationRoute | CC BY-NC | 33619146 | 19,020,282 | 2021-02-22 |
What was the administration route of drug 'METHOTREXATE'? | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33619146 | 19,020,282 | 2021-02-22 |
What was the administration route of drug 'SECUKINUMAB'? | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33619146 | 19,002,719 | 2021-02-22 |
What was the administration route of drug 'SULFASALAZINE'? | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | Oral | DrugAdministrationRoute | CC BY-NC | 33619146 | 19,020,282 | 2021-02-22 |
What was the outcome of reaction 'Sarcoidosis'? | Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Sarcoidosis is a multisystem inflammatory disorder of uncertain aetiology. There are numerous case reports of sarcoidosis occurring during treatment with biological immunotherapies. Here, we describe the case of a 52-year-old woman with ... | Recovering | ReactionOutcome | CC BY-NC | 33619146 | 19,002,719 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Longitudinal and multi-tissue molecular diagnostics track somatic BRCA2 reversion mutations that correct the open reading frame of germline alteration upon clinical relapse.
BRCA-mutant cancers often develop therapeutic resistance through several mechanisms. Here, we report a case of pathogenic germline BRCA2-driven br... | CARBOPLATIN, GEMCITABINE, OLAPARIB | DrugsGivenReaction | CC BY | 33619265 | 19,694,252 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone disorder'. | First prospective data on breast cancer patients from the multicentre italian bone metastasis database.
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At pre... | DENOSUMAB | DrugsGivenReaction | CC BY | 33619285 | 18,321,151 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | First prospective data on breast cancer patients from the multicentre italian bone metastasis database.
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At pre... | DENOSUMAB | DrugsGivenReaction | CC BY | 33619285 | 18,321,151 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to bone'. | First prospective data on breast cancer patients from the multicentre italian bone metastasis database.
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At pre... | DENOSUMAB | DrugsGivenReaction | CC BY | 33619285 | 18,321,151 | 2021-02-22 |
What was the outcome of reaction 'Death'? | First prospective data on breast cancer patients from the multicentre italian bone metastasis database.
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At pre... | Fatal | ReactionOutcome | CC BY | 33619285 | 18,321,151 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal wall haematoma'. | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | DEXAMETHASONE, ENOXAPARIN, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | DEXAMETHASONE, ENOXAPARIN, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
What was the administration route of drug 'DEXAMETHASONE'? | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
What was the administration route of drug 'REMDESIVIR'? | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
What was the dosage of drug 'ENOXAPARIN'? | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | 80 MILLIGRAM, BID | DrugDosageText | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
What was the dosage of drug 'REMDESIVIR'? | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | 6 DOSAGE FORM | DrugDosageText | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
What was the outcome of reaction 'Abdominal wall haematoma'? | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
What was the outcome of reaction 'Haemorrhage'? | Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Multiple studies and reports have suggested that coronavirus disease-19 (COVID-19) promotes arterial and venous thrombotic events in multiple organ systems, although the mechanism leading to a hypercoagulable state is still unknown. Few cas... | Recovered | ReactionOutcome | CC BY-NC-ND | 33619439 | 19,173,777 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient.
Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary... | DEXAMETHASONE, MEROPENEM, VORICONAZOLE | DrugsGivenReaction | CC BY | 33619451 | 19,773,167 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory disorder'. | Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient.
Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary... | DEXAMETHASONE, MEROPENEM, VORICONAZOLE | DrugsGivenReaction | CC BY | 33619451 | 19,773,167 | 2021 |
What was the outcome of reaction 'Cardiac failure'? | Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient.
Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary... | Fatal | ReactionOutcome | CC BY | 33619451 | 19,773,167 | 2021 |
What was the outcome of reaction 'Respiratory disorder'? | Fatal VAP-related pulmonary aspergillosis by Aspergillus niger in a positive COVID-19 patient.
Invasive pulmonary aspergillosis, known as a complication in patients with severe respiratory syndromes, recently showed a correlation with COVID-19 pneumonia, and the clinical characteristics of COVID-19 associated pulmonary... | Fatal | ReactionOutcome | CC BY | 33619451 | 19,773,167 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry.
The state of Kentucky has the highest cancer incidence and mortality in the United States. High-risk populations such as this are often underrepresent... | ATEZOLIZUMAB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33619913 | 19,777,723 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry.
The state of Kentucky has the highest cancer incidence and mortality in the United States. High-risk populations such as this are often underrepresent... | ATEZOLIZUMAB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33619913 | 19,777,723 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune system disorder'. | Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry.
The state of Kentucky has the highest cancer incidence and mortality in the United States. High-risk populations such as this are often underrepresent... | ATEZOLIZUMAB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33619913 | 19,777,723 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | CYCLOPHOSPHAMIDE, PREDNISONE | DrugsGivenReaction | CC BY | 33620515 | 19,002,502 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental status changes'. | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | CYCLOPHOSPHAMIDE, HYDRALAZINE HYDROCHLORIDE, PREDNISONE | DrugsGivenReaction | CC BY | 33620515 | 20,043,816 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | CYCLOPHOSPHAMIDE, PREDNISONE | DrugsGivenReaction | CC BY | 33620515 | 19,002,502 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | CREATININE, CYCLOPHOSPHAMIDE, PREDNISONE | DrugsGivenReaction | CC BY | 33620515 | 19,100,880 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vasculitis'. | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | CREATININE, CYCLOPHOSPHAMIDE, PREDNISONE | DrugsGivenReaction | CC BY | 33620515 | 19,100,880 | 2021-07 |
What was the dosage of drug 'CORTICOSTEROID NOS'? | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | UNK, 2 /DAY | DrugDosageText | CC BY | 33620515 | 19,039,551 | 2021-07 |
What was the dosage of drug 'CREATININE'? | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | 2 MG/DL | DrugDosageText | CC BY | 33620515 | 19,100,880 | 2021-07 |
What was the outcome of reaction 'Clostridium difficile colitis'? | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | Recovered | ReactionOutcome | CC BY | 33620515 | 20,043,816 | 2021-07 |
What was the outcome of reaction 'Escherichia bacteraemia'? | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | Recovered | ReactionOutcome | CC BY | 33620515 | 20,043,816 | 2021-07 |
What was the outcome of reaction 'Human herpesvirus 8 infection'? | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | Recovered | ReactionOutcome | CC BY | 33620515 | 20,043,816 | 2021-07 |
What was the outcome of reaction 'Urosepsis'? | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | Recovered | ReactionOutcome | CC BY | 33620515 | 20,043,816 | 2021-07 |
What was the outcome of reaction 'Vasculitis'? | Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides associated with significant morbidity and mortality. Given the immunosuppression used to manage these conditions, it i... | Recovered | ReactionOutcome | CC BY | 33620515 | 19,100,880 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | ALFACALCIDOL, BELIMUMAB, CYCLOPHOSPHAMIDE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, RITUXIMAB, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33622323 | 19,076,387 | 2021-02-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | ALFACALCIDOL, BELIMUMAB, CYCLOPHOSPHAMIDE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, RITUXIMAB, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33622323 | 19,076,387 | 2021-02-23 |
What is the weight of the patient? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | 44.2 kg. | Weight | CC BY | 33622323 | 20,220,667 | 2021-02-23 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33622323 | 19,072,142 | 2021-02-23 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33622323 | 19,076,387 | 2021-02-23 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33622323 | 19,072,142 | 2021-02-23 |
What was the dosage of drug 'HYDROXYCHLOROQUINE SULFATE'? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | 200 MILLIGRAM, DAILY | DrugDosageText | CC BY | 33622323 | 19,076,387 | 2021-02-23 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | 200 MILLIGRAM DAILY; | DrugDosageText | CC BY | 33622323 | 19,072,142 | 2021-02-23 |
What was the dosage of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | 1 GRAM, QD, PULSE THERAPY | DrugDosageText | CC BY | 33622323 | 19,076,387 | 2021-02-23 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL HYDROCHLORIDE'? | Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report.
BACKGROUND
Systemic lupus erythematosus is a multi-organ inflammatory autoimmune disease; immune complexes are part of the pathogenesis, but not entirely responsible. Trisomy X is the most common fe... | 1500 MILLIGRAM, DAILY | DrugDosageText | CC BY | 33622323 | 19,076,387 | 2021-02-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | AZITHROMYCIN ANHYDROUS, CIPROFLOXACIN, CLARITHROMYCIN, CLOFAZIMINE, LINEZOLID, MEROPENEM, MOXIFLOXACIN, RIFABUTIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 33622490 | 19,166,590 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | AZITHROMYCIN ANHYDROUS, CIPROFLOXACIN, CLARITHROMYCIN, CLOFAZIMINE, LINEZOLID, MEROPENEM, MOXIFLOXACIN, RIFABUTIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 33622490 | 19,166,590 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | AMIKACIN, AZITHROMYCIN ANHYDROUS, BEDAQUILINE, CIPROFLOXACIN, CLOFAZIMINE, ETHAMBUTOL HYDROCHLORIDE, LINEZOLID, MEROPENEM, MOXIFLOXACIN, RIFABUTIN, TEDIZOLID, TIGECYCLINE | DrugsGivenReaction | CC BY | 33622490 | 19,188,929 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | AZITHROMYCIN ANHYDROUS, CIPROFLOXACIN, CLARITHROMYCIN, CLOFAZIMINE, LINEZOLID, MEROPENEM, MOXIFLOXACIN, RIFABUTIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 33622490 | 19,166,590 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | AMIKACIN, AZITHROMYCIN ANHYDROUS, BEDAQUILINE, CLOFAZIMINE, IMIPENEM, MOXIFLOXACIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 33622490 | 19,096,291 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tinnitus'. | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | AMIKACIN, AZITHROMYCIN ANHYDROUS, BEDAQUILINE, CLOFAZIMINE, IMIPENEM, MOXIFLOXACIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 33622490 | 19,096,291 | 2021-03 |
What was the administration route of drug 'AMIKACIN'? | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33622490 | 19,096,291 | 2021-03 |
What was the outcome of reaction 'Drug ineffective'? | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | Not recovered | ReactionOutcome | CC BY | 33622490 | 19,166,590 | 2021-03 |
What was the outcome of reaction 'Renal impairment'? | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | Recovered | ReactionOutcome | CC BY | 33622490 | 19,096,291 | 2021-03 |
What was the outcome of reaction 'Toxicity to various agents'? | Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug trea... | Recovered | ReactionOutcome | CC BY | 33622490 | 19,096,291 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspartate aminotransferase increased'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus infection reactivation'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN\CLAVULANATE POTASSIUM, DIPHENHYDRAMINE, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,009,695 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatomegaly'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN\CLAVULANIC ACID, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,053,028 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inappropriate schedule of product administration'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN\CLAVULANATE POTASSIUM, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,054,231 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product misuse'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN\CLAVULANIC ACID, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,053,028 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN\CLAVULANIC ACID, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,053,028 | 2021-02-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | AMOXICILLIN, MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33622999 | 19,053,028 | 2021-02-24 |
What was the administration route of drug 'MINOCYCLINE HYDROCHLORIDE'? | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33622999 | 19,053,028 | 2021-02-24 |
What was the dosage of drug 'MINOCYCLINE HYDROCHLORIDE'? | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
What was the outcome of reaction 'Alanine aminotransferase increased'? | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | Recovering | ReactionOutcome | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
What was the outcome of reaction 'Aspartate aminotransferase increased'? | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | Recovering | ReactionOutcome | CC BY-NC-ND | 33622999 | 19,047,119 | 2021-02-24 |
What was the outcome of reaction 'Drug reaction with eosinophilia and systemic symptoms'? | Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug-induced hypersensitivity reaction that can result in a severe cutaneous adverse drug reaction (SCAR). It is a rare and ... | Recovering | ReactionOutcome | CC BY-NC-ND | 33622999 | 19,053,028 | 2021-02-24 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.